Iron accumulation in the substantia nigra in rats visualized by ultrasound

被引:159
作者
Berg, D
Grote, C
Rausch, WD
Mäurer, M
机构
[1] Univ Wurzburg, Dept Neurol, D-8700 Wurzburg, Germany
[2] Univ Wurzburg, Dept Psychiat, Inst Clin Neurochem, D-8700 Wurzburg, Germany
[3] Univ Marburg, Inst Physiol Chem, Marburg, Germany
[4] Vet Med Univ, Inst Med Chem, Vienna, Austria
关键词
transcranial ultrasound; ultrasound; substantia nigra; animal model; iron; protein-bound iron; ferritin; 6-OHDA; desferrioxamine; spectroscopy;
D O I
10.1016/S0301-5629(99)00046-0
中图分类号
O42 [声学];
学科分类号
070206 ; 082403 ;
摘要
In recent studies, we have found a marked increase in substantia nigra (SN) echogenicity in patients with Parkinson's disease (PD) using transcranial ultrasound. Because a substantial body of evidence has accumulated indicating a selective elevation of iron in the SN from patients with PD, we set out to test the hypothesis that trace metals like iron could lead to the observed increase of SN echogenicity in PD, Rat brains were scanned after stereotactic injection of iron in different concentrations into the SN and after injecting ferritin, zinc and 6-OHDA alone, and after the addition of desferrioxamine. The amount of iron in the SN was measured spectroscopically. For iron, and partly for 6-OHDA, in different concentrations, a dose-dependent increase of SN echogenicity could be visualized, corresponding to an increase of iron measured by spectroscopy. No increase of echogenicity was visualized after the injection of ferritin and the addition of desferrioxamine to 6-OHDA, though an increase of iron was measured by spectroscopy. Therefore, we conclude that iron not bound to these proteins may lead to an increase of echogenicity of the SN. (C) 1999 World Federation for Ultrasound in Medicine & Biology.
引用
收藏
页码:901 / 904
页数:4
相关论文
共 29 条
  • [1] The microglial cell. A historical review
    Barron, KD
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 1995, 134 : 57 - 68
  • [2] DEGENERATION OF SUBSTANTIA-NIGRA IN CHRONIC PARKINSONS-DISEASE VISUALIZED BY TRANSCRANIAL COLOR-CODED REAL-TIME SONOGRAPHY
    BECKER, G
    SEUFERT, J
    BOGDAHN, U
    REICHMANN, H
    REINERS, K
    [J]. NEUROLOGY, 1995, 45 (01) : 182 - 184
  • [3] Becker G, 1993, TRANSCRANIAL DOPPLER, P51
  • [4] THE IRON CHELATOR DESFERRIOXAMINE (DESFERAL) RETARDS 6-HYDROXYDOPAMINE-INDUCED DEGENERATION OF NIGROSTRIATAL DOPAMINE NEURONS
    BENSHACHAR, D
    ESHEL, G
    FINBERG, JPM
    YOUDIM, MBH
    [J]. JOURNAL OF NEUROCHEMISTRY, 1991, 56 (04) : 1441 - 1444
  • [5] Bogdahn U, 1998, ECHOENHANCERS AND TRANSCRANIAL COLOR DUPLEX SONOGRAPHY, P232
  • [6] CELLULAR-DISTRIBUTION OF TRANSFERRIN, FERRITIN, AND IRON IN NORMAL AND AGED HUMAN BRAINS
    CONNOR, JR
    MENZIES, SL
    STMARTIN, SM
    MUFSON, EJ
    [J]. JOURNAL OF NEUROSCIENCE RESEARCH, 1990, 27 (04) : 595 - 611
  • [7] INCREASED NIGRAL IRON CONTENT AND ALTERATIONS IN OTHER METAL-IONS OCCURRING IN BRAIN IN PARKINSONS-DISEASE
    DEXTER, DT
    WELLS, FR
    LEES, AJ
    AGID, F
    AGID, Y
    JENNER, P
    MARSDEN, CD
    [J]. JOURNAL OF NEUROCHEMISTRY, 1989, 52 (06) : 1830 - 1836
  • [8] ALTERATIONS IN THE LEVELS OF IRON, FERRITIN AND OTHER TRACE-METALS IN PARKINSONS-DISEASE AND OTHER NEURODEGENERATIVE DISEASES AFFECTING THE BASAL GANGLIA
    DEXTER, DT
    CARAYON, A
    JAVOYAGID, F
    AGID, Y
    WELLS, FR
    DANIEL, SE
    LEES, AJ
    JENNER, P
    MARSDEN, CD
    [J]. BRAIN, 1991, 114 : 1953 - 1975
  • [9] DEXTER DT, 1993, ADV NEUROL, V60, P273
  • [10] Double KL, 1998, J NEUROCHEM, V70, P2492